Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T15:01:32.137Z.
Calculation as of: 2026-10-06T15:01:32.137Z.
Quote observation: 2026-10-06T15:00:21.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6a2f90c369cc2bba861e7882df5fb589e6a534c6c6a3ec3aca589af2a274c9b5
EARNINGS YIELD
N/A
Anteris Technologies Global Corp.
Market Cap
$695.21M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$707.95M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$709.16M
Earnings Yield
5.67%
TTM Avg
4.56%
3Y Avg
4.80%
5Y Avg
6.03%
Market Cap
$721.26M
Earnings Yield
N/A
TTM Avg
0.13%
3Y Avg
0.36%
5Y Avg
0.36%
Market Cap
$665.48M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$719.62M
Earnings Yield
N/A
TTM Avg
0.35%
3Y Avg
0.35%
5Y Avg
0.35%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Anteris Technologies Global Corp. (AVR) | $695.21M | N/A | N/A | N/A | N/A |
| Faeth Therapeutics, Inc. (FTH)vs › | $704.02M | N/A | N/A | N/A | N/A |
| Annexon, Inc. (ANNX)vs › | $679.13M | N/A | N/A | N/A | N/A |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $707.95M | N/A | N/A | N/A | N/A |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $709.16M | 5.67% | 4.56% | 4.80% | 6.03% |
| Cytek Biosciences, Inc. (CTKB)vs › | $721.26M | N/A | 0.13% | 0.36% | 0.36% |
| Helus Pharma Inc. (HELP)vs › | $666.95M | N/A | N/A | N/A | N/A |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $665.48M | N/A | N/A | N/A | N/A |
| Avalo Therapeutics, Inc. (AVTX)vs › | $719.62M | N/A | 0.35% | 0.35% | 0.35% |
| MiMedx Group, Inc. (MDXG)vs › | $665.40M | 0.88% | 4.56% | 4.76% | 4.76% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
